DLX6 and cancer: Through GSEA KEGG enrichment analysis using sequencing and clinical data from patients at Fujian Cancer Hospital, we found that DLX6 was significantly enriched in t cell cycle, DNA replication, ECM receptor reaction and pathways in cancer (Figure 2A).